o2h Ventures is a leading investment firm which specialises in backing biotech companies, offering private investors the opportunity to back promising medical innovations via the Enterprise Investment Scheme (EIS) and the Seed Investment Scheme (SEIS). It is the only firm, believes the management, that specialises in biotech therapeutics, as a deep technical expertise is required to analyse such businesses. The company is based in Cambridge, UK. Managing Partners are brothers Sunil (CEO) and Prashant Shah. Both have been working in the biotech/pharma space most of their careers and have invested personally in around 20 biotech companies, mainly in the Cambridge area.
o2h has developed an engine for seeding a pipeline of early stage life science assets through research collaborations, in-licensing, spin-outs & investment.
o2h has an emerging portfolio of seed stage investments in frontier technology companies, and the crossover field of digital health.
The DNA of o2h is centred around the nurturing of its people, values and culture, it reflects in the way we work with each other, as well as our collaborators and partners.
Our set of values are centred around the speed at which we learn, innovation, teamwork, attention to detail, energy, delivery, integrity, and community.